Shireen Davies
CEO and Co-Founder
,
SOLASTA® BIO
Shireen Davies is CEO and co-founder of SOLASTA® Bio, successfully team building and securing financing to develop SOLASTA from a 2021 University spinout to scale-up company.
SOLASTA's proprietary platform technology for small peptide bioinsecticides has rapidly demonstrated high field efficacy comparable to chemical standards against four insect targets.
With a US EPA biochemical classification, SOLASTA’s first aphid product is in development.
Sessions
-
Scale-Up Case Studies // AI, Data Science, and Biotechnology17-Mar-2026Start-Up Arena
)
){kind=logo}
)
){kind=logo}
)
)
){kind=logo}
)
)
){kind=logo}
)
)
)
)
)
){kind=logo}
)
)
)
)
)
)
)
)
)
)
)
)
)
)
){kind=logo}
){kind=logo}
)
)
)
)